Skip to main content
Premium Trial:

Request an Annual Quote

Wendy Blosser, Jasmine Gruia-Gray, Robin Cowie

Biodesix announced that it has hired Wendy Blosser as its new VP of sales, and has promoted Jasmine Gruia-Gray to the post of VP of marketing and Robin Cowie to the role of VP of reimbursement and healthcare economics.

Blosser joins the firm from Integrated Oncology, a subsidiary of Laboratory Corporation of America, where she held the position of US VP of sales. She also previously worked in sales at Vermillion and Precision Therapeutics.

Gruia-Gray joined Biodesix last year after serving as VP of global marketing for Affymetrix. Cowie joined Biodesix in 2011 as the firm's first director of reimbursement.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.